scPharmaceuticals Inc (SCPH)
4.56
+0.09
(+2.01%)
USD |
NASDAQ |
May 01, 16:00
4.55
-0.01
(-0.22%)
Pre-Market: 20:00
scPharmaceuticals Price: 4.56 for May 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 01, 2024 | 4.48 | 4.70 | 4.46 | 4.56 | 87475.00 |
Apr 30, 2024 | 4.55 | 4.58 | 4.40 | 4.47 | 184913.0 |
Apr 29, 2024 | 4.52 | 4.71 | 4.49 | 4.58 | 194134.0 |
Apr 26, 2024 | 4.38 | 4.58 | 4.32 | 4.49 | 119733.0 |
Apr 25, 2024 | 4.47 | 4.55 | 4.27 | 4.35 | 187355.0 |
Apr 24, 2024 | 4.64 | 4.75 | 4.49 | 4.50 | 92041.00 |
Apr 23, 2024 | 4.63 | 4.79 | 4.57 | 4.61 | 85259.00 |
Apr 22, 2024 | 4.58 | 4.66 | 4.45 | 4.57 | 113931.0 |
Apr 19, 2024 | 4.50 | 4.62 | 4.41 | 4.56 | 166627.0 |
Apr 18, 2024 | 4.42 | 4.52 | 4.25 | 4.51 | 223905.0 |
Apr 17, 2024 | 4.69 | 4.755 | 4.41 | 4.42 | 249573.0 |
Apr 16, 2024 | 4.86 | 4.90 | 4.67 | 4.67 | 126229.0 |
Apr 15, 2024 | 4.89 | 4.97 | 4.75 | 4.86 | 184123.0 |
Apr 12, 2024 | 5.09 | 5.13 | 4.93 | 4.93 | 137212.0 |
Apr 11, 2024 | 4.78 | 5.11 | 4.78 | 5.10 | 146186.0 |
Apr 10, 2024 | 4.88 | 4.90 | 4.70 | 4.78 | 248847.0 |
Apr 09, 2024 | 4.94 | 5.12 | 4.831 | 5.02 | 160279.0 |
Apr 08, 2024 | 5.02 | 5.08 | 4.89 | 4.93 | 138789.0 |
Apr 05, 2024 | 5.18 | 5.18 | 4.98 | 5.03 | 202699.0 |
Apr 04, 2024 | 5.22 | 5.33 | 5.07 | 5.14 | 163569.0 |
Apr 03, 2024 | 4.76 | 5.31 | 4.71 | 5.21 | 258758.0 |
Apr 02, 2024 | 4.78 | 4.86 | 4.65 | 4.78 | 178690.0 |
Apr 01, 2024 | 4.97 | 4.97 | 4.77 | 4.85 | 216635.0 |
Mar 28, 2024 | 5.13 | 5.155 | 4.97 | 5.02 | 110060.0 |
Mar 27, 2024 | 5.05 | 5.16 | 4.87 | 5.03 | 229540.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.93
Minimum
Jun 24 2019
11.74
Maximum
May 12 2023
6.444
Average
6.07
Median
Jan 07 2020
Price Benchmarks
Anika Therapeutics Inc | 26.44 |
Spero Therapeutics Inc | 1.54 |
electroCore Inc | 6.20 |
NovaBay Pharmaceuticals Inc | 0.0896 |
Palatin Technologies Inc | 1.87 |
Price Related Metrics
PS Ratio | 12.92 |
Price to Book Value | 4.417 |
Earnings Yield | -31.14% |
Market Cap | 164.41M |